Category Archives: Myocardial Infarction

Evolve Business Intelligence published a new market research report on Global Cardiac Biomarkers Market by Product Type (Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Troponins (T and I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia-modified Albumin (IMA), and Others), by Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), by Location of Testing (Laboratory testing and Point of Care Testing) and By Geography COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends, and Forecast from 2022 to 2032 The global Cardiac Biomarkers market Size Is Expected To Grow At A CAGR Of Approx. 12% From 2022 To 2032. The Cardiac Biomarkers Market report provides data on industry size and growth rate, globally and by region. Continue reading →

Stanford Health Care has been ranked #10 best hospital overall by US News and World Report for 2022-2023. Continue reading →

By Matthew Stenger Posted: 8/4/2022 3:08:00 PM Last Updated: 8/4/2022 2:16:18 PM In a phase II trial reported in JAMA Oncology, Derman et al found that a measurable residual disease (MRD)-adapted strategy with elotuzumab (Elo) plus carfilzomib, lenalidomide, and dexamethasone (KRd) was associated with high rates of stringent complete response and MRD-negative status in patients with newly diagnosed multiple myeloma with no intent for transplantation. Study Details In the U.S. multicenter study, 46 patients enrolled between July 2017 and February 2021 received 12 to 24 28-day cycles of Elo-KRd Continue reading →

Investment analysts at StockNews.com initiated coverage on shares of InspireMD (NYSE:NSPR Get Rating) in a report issued on Tuesday. The firm set a sell rating on the stock. Shares of InspireMD stock opened at $2.05 on Tuesday. Continue reading →

The COVID-19pandemic has left a lasting impact on the world. It has infected more than 359 million people worldwide, resulting in more than 5.6 million deaths [1]. In the time that has passed since the first known cases were reported in late 2019, the scientific community has learned a great amount about this new virus Continue reading →

technology Myocardial Infarction Test Kit market analysis report is produced in such a way that it works toward making the reports easier to read, and easier for managers to absorb the information they need to make decisions. The market information of this report is made more accessible to the clients. This industry analysis report contains actionable research and is also educational and entertaining. Continue reading →

HANOVER, Germany--(BUSINESS WIRE)--Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the dosing of the first patient in their multicenter Phase 2 trial assessing efficacy and safety of CDR132L in 280 patients with reduced left ventricular ejection fraction after myocardial infarction (HF-REVERT). Continue reading →

The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer-reviewed. Machine learning identified five subtypes in incident heart failure (HF) with good predictive accuracy for 1-year all-cause mortality. Future trials and clinical practice might be able to use the electronic health record (EHR) and machine learning to identify HF subtypes to aid in management and prognosis. Continue reading →

Heart attacks seem like they happen out of nowhere, but oftentimes there are warning signs that were missed. Nobody thinks they're going to have a heart attack, but every 40 seconds someone in the United States has one. Continue reading →

Angina is a symptom of ischemia to your heart. Ischemia is when proper blood flow is affected. When your heart doesnt get enough blood or oxygen, chest pain can occur Continue reading →